rroodd
IMO
Great debating of valid points
Talking up funding during inflection points as value adding is laughable at best imo
Each readout has only led to cheaper CR's and share price
This stock is not a secret dual listed and marketed by Genentech worldwide after phase 1 study
Share price cheaper than prior to GDC0084 says all to how credible those arguments are imo
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-481
-
-
- There are more pages in this discussion • 1,586 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)